Ligand Pharmaceuticals LGND Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's current ratio?
- Ligand Pharmaceuticals (LGND) reported current ratio of 21.3× in Q1 2026.
- How has Ligand Pharmaceuticals's current ratio changed year-over-year?
- Ligand Pharmaceuticals's current ratio increased by 303.7% year-over-year, from 5.3× to 21.3×.
- What is the long-term trend for Ligand Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's current ratio has grown at a 34.8% compound annual growth rate (CAGR), from 5× to 22.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.